Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R S Liou

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1990
Monoclonal anti-idiotypic antibody mimicking the principal neutralization site in HIV-1 GP120 induces HIV-1 neutralizing antibodies in rabbitsM S Fung, C R Sun, R S Liou, et al.
Journal of Virology|April 1, 1983
Molecular cloning and analysis of the endogenous retrovirus chemically induced from RFM/Un mouse cell culturesR S Liou, L R Boone, J O Kiggans, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1989
A chimeric mouse-human antibody that retains specificity for HIV gp120 and mediates the lysis of HIV-infected cellsR S Liou, E M Rosen, M S Fung, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 11, 1991
Transfectomas expressing both secreted and membrane-bound forms of chimeric IgE with anti-viral specificityL K Sun, R S Liou, N C Sun, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1992
Mouse/human chimeric anti-HIV-1 gp120 antibody to the principal neutralizing determinant: tolerability and pharmacokinetics in cynomolgus monkeys, Macaca fascicularisR S Liou, M S Fung, U Zühlke, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1993
Pharmacokinetics of an HIV-1 gp120-specific chimeric antibody in patients with HIV-1 diseaseJ Schüpbach, H Günthard, M S Fung, et al.
Human Antibodies and Hybridomas|January 1, 1994
Construction and characterization of chimeric and humanized forms of a broadly neutralizing monoclonal antibody to HIV-1J G Major, R S Liou, L K Sun, et al.
Journal of Virology|February 1, 1992
Identification and characterization of a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120M S Fung, C R Sun, W L Gordon, et al.
The Journal of Infectious Diseases|December 1, 1994
A phase I/IIA clinical study with a chimeric mouse-human monoclonal antibody to the V3 loop of human immunodeficiency virus type 1 gp120H F Günthard, P L Gowland, J Schüpbach, et al.
Clinical Pharmacology and Therapeutics|January 20, 1998
Efficacy, pharmacodynamics, and pharmacokinetics of CGP 51901, an anti-immunoglobulin E chimeric monoclonal antibody, in patients with seasonal allergic rhinitisA Racine-Poon, L Botta, T W Chang, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1990
Monoclonal anti-idiotypic antibody mimicking the principal neutralization site in HIV-1 GP120 induces HIV-1 neutralizing antibodies in rabbitsM S Fung, C R Sun, R S Liou, et al.
Journal of Virology|April 1, 1983
Molecular cloning and analysis of the endogenous retrovirus chemically induced from RFM/Un mouse cell culturesR S Liou, L R Boone, J O Kiggans, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1989
A chimeric mouse-human antibody that retains specificity for HIV gp120 and mediates the lysis of HIV-infected cellsR S Liou, E M Rosen, M S Fung, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 11, 1991
Transfectomas expressing both secreted and membrane-bound forms of chimeric IgE with anti-viral specificityL K Sun, R S Liou, N C Sun, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1992
Mouse/human chimeric anti-HIV-1 gp120 antibody to the principal neutralizing determinant: tolerability and pharmacokinetics in cynomolgus monkeys, Macaca fascicularisR S Liou, M S Fung, U Zühlke, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1993
Pharmacokinetics of an HIV-1 gp120-specific chimeric antibody in patients with HIV-1 diseaseJ Schüpbach, H Günthard, M S Fung, et al.
Human Antibodies and Hybridomas|January 1, 1994
Construction and characterization of chimeric and humanized forms of a broadly neutralizing monoclonal antibody to HIV-1J G Major, R S Liou, L K Sun, et al.
Journal of Virology|February 1, 1992
Identification and characterization of a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120M S Fung, C R Sun, W L Gordon, et al.
The Journal of Infectious Diseases|December 1, 1994
A phase I/IIA clinical study with a chimeric mouse-human monoclonal antibody to the V3 loop of human immunodeficiency virus type 1 gp120H F Günthard, P L Gowland, J Schüpbach, et al.
Clinical Pharmacology and Therapeutics|January 20, 1998
Efficacy, pharmacodynamics, and pharmacokinetics of CGP 51901, an anti-immunoglobulin E chimeric monoclonal antibody, in patients with seasonal allergic rhinitisA Racine-Poon, L Botta, T W Chang, et al.
Pageof 3